FAM173A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.440200E-01
Normal-vs-Stage2
4.582200E-01
Normal-vs-Stage3
9.306200E-01
Normal-vs-Stage4
6.153200E-01
Stage1-vs-Stage2
3.256000E-01
Stage1-vs-Stage3
3.820200E-01
Stage1-vs-Stage4
2.642600E-01
Stage2-vs-Stage3
4.743000E-01
Stage2-vs-Stage4
8.458200E-02
Stage3-vs-Stage4
9.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.280400E-01
Normal-vs-AfricanAmerican
6.721000E-01
Normal-vs-Asian
2.282600E-01
Caucasian-vs-AfricanAmerican
7.782000E-01
Caucasian-vs-Asian
1.325240E-01
AfricanAmerican-vs-Asian
2.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.907800E-01
Normal-vs-Female
5.149200E-01
Male-vs-Female
1.097990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.190200E-01
Normal-vs-Age(41-60Yrs)
5.446600E-01
Normal-vs-Age(61-80Yrs)
4.323600E-01
Normal-vs-Age(81-100Yrs)
2.748400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.165600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.497400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.835400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.818960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.600620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.280400E-01
Normal-vs-Daily Drinker
1.825390E-01
Normal-vs-Weekly Drinker
1.839220E-01
Normal-vs-Occasional Drinker
4.937800E-01
Normal-vs-Social Drinker
4.790200E-01
Non Drinker-vs-Daily Drinker
3.762600E-01
Non Drinker-vs-Weekly Drinker
2.012400E-01
Non Drinker-vs-Occasional Drinker
4.557600E-01
Non Drinker-vs-Social Drinker
5.272800E-01
Daily Drinker-vs-Weekly Drinker
4.678600E-01
Daily Drinker-vs-Occasional Drinker
1.827750E-01
Daily Drinker-vs-Social Drinker
2.313000E-01
Weekly Drinker-vs-Occasional Drinker
8.851700E-02
Weekly Drinker-vs-Social Drinker
1.194400E-01
Occasional Drinker-vs-Social Drinker
9.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.400400E-01
Normal-vs-Grade 2
1.999590E-01
Normal-vs-Grade 3
1.811250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.860800E-01
Grade 1-vs-Grade 3
5.148400E-01
Grade 1-vs-Grade 4
3.400400E-01
Grade 2-vs-Grade 3
5.409600E-01
Grade 2-vs-Grade 4
1.999590E-01
Grade 3-vs-Grade 4
1.811250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.289200E-01
Normal-vs-NonDiabetic
2.996200E-01
Diabetic-vs-NonDiabetic
6.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.799800E-02
Normal-vs-NoPancreatitis
3.599600E-01
Pancreatitis-vs-NoPancreatitis
3.643800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.226600E-01
Normal-vs-N1
5.027400E-01
N0-vs-N1
1.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.185600E-01
Normal-vs-TP53-NonMutant
7.009200E-01
TP53-Mutant-vs-TP53-NonMutant
4.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
